Hydralazine Hydrochloride Tablet
FDA Label NDC 55154-5689

21 label sections · Submitted to the FDA by Cardinal Health 107, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Cardinal Health 107, Llc for the product Hydralazine Hydrochloride (NDC 55154-5689). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, clinical pharmacology, indications and usage, contraindications, warnings, general, information for patients, laboratory tests, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel

NDC 55154-5689-0

HydrALAZINE HYDROCHLORIDE

TABLETS, USP 25 mg

10 TABLETS

25mg Bag Label (3a8625af Ede6 2b68 E063 6394a90a4536 01)

25mg Bag Label (3a8625af Ede6 2b68 E063 6394a90a4536 01)

NDC 55154-5085-0

HydrALAZINE HYDROCHLORIDE

TABLETS, USP 50 mg

10 TABLETS

50mg Bag Label (3a8625af Ede6 2b68 E063 6394a90a4536 00)

50mg Bag Label (3a8625af Ede6 2b68 E063 6394a90a4536 00)

* Please review the disclaimer below.